Related Experiment Videos
Chemotherapy for extraocular retinoblastoma
C B Pratt1, J Fontanesi, P Chenaille
1Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38101-0318.
Pediatric Hematology and Oncology
|May 1, 1994
Summary
Chemotherapy before radiotherapy showed promise for extraretinal retinoblastoma. Further research into optimal chemotherapy combinations is needed for this rare cancer.
Area of Science:
- Oncology
- Ophthalmology
Background:
- Extraretinal retinoblastoma is rare in Western countries, complicating treatment strategy development.
- Optimal chemotherapy regimens for advanced retinoblastoma require further investigation.
Observation:
- This study evaluated two chemotherapy combinations (cisplatin/etoposide and cyclophosphamide/doxorubicin) in four patients with extraretinal retinoblastoma.
- Chemotherapy was administered before radiotherapy for recurrent or advanced primary disease.
Findings:
- Treatment responses were assessed in three patients who received both chemotherapy regimens and radiotherapy.
- Multimodality therapy, including chemotherapy and radiotherapy, demonstrated potential benefits.
Implications:
- Chemotherapy combined with radiotherapy offers a promising approach for managing extraretinal retinoblastoma.
- Future studies should investigate novel chemotherapy combinations to improve outcomes for this ocular malignancy.